GSK-207652

Study Sponsor: GSK

Study Title

Randomized, open label, 2-way crossover, single dose bioequivalence study of Paroxetine IR tablets manufactured in GSKT and Mississauga sites in healthy Chinese participants under fasting and fed conditions

Medicine or Vaccine (generic name)

paroxetine

Sponsor Identification Number

207652

Trial Registry Identification Number(#'s)

NCT03329573

Medical Condition

Anxiety Disorders

Phase

Phase 1

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=207652

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT03329573

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An annotated case report form is not available for this study. A blank case report form will be provided. This study is available in CDISC format.

Date Added to this Site

February 2020